DR. ALLEN WAYNE MANGEL, MD
Medical Practice at Ukiah Ln, Chapel Hill, NC
License number
North Carolina 39193
Category
Medical Practice
Type
Research Study
Address
Address
208 Ukiah Ln, Chapel Hill, NC 27514
Phone
(919) 931-9862
(919) 541-1275 (Fax)
(919) 541-1275 (Fax)
Personal information
See more information about ALLEN WAYNE MANGEL at radaris.comName
Address
Phone
Chapel Hill, NC
102 Callard Run, Chapel Hill, NC 27514
208 Ukiah Ln, Chapel Hill, NC 27514
208 Ukiah Ln, Chapel Hill, NC 27514
Professional information
Dr. Allen W Mangel, Chapel Hill NC - MD (Doctor of Medicine)
Specialties:
Gastroenterology
Address:
208 Ukiah Ln, Chapel Hill 27514
(919) 931-9862 (Phone), (919) 541-1275 (Fax)
(919) 931-9862 (Phone), (919) 541-1275 (Fax)
Languages:
English
Education:
Medical School
Georgetown University
Graduated: 1988
Georgetown University
Graduated: 1988
Use Of Cox-2 Inhibitors As Gastroprokinetics
US Patent:
6759413, Jul 6, 2004
Filed:
Jul 25, 2002
Appl. No.:
10/182080
Inventors:
Allen Wayne Mangel - Chapel Hill NC
Alan Naylor - Stevenage, GB
Alan Naylor - Stevenage, GB
Assignee:
SmithKline Beecham Corporation - Philadelphia PA
International Classification:
A61K 315025
US Classification:
514248
Abstract:
The invention provides a COX-2 inhibitor or a pharmaceutically acceptable derivative thereof for use in the treatment of a disorder ameliorated by a gastroprokinetic.
Methods For Treating Irritable Bowel Syndrome
US Patent:
6429209, Aug 6, 2002
Filed:
Apr 13, 2001
Appl. No.:
09/834717
Inventors:
Allen Wayne Mangel - Chapel Hill NC
Allison Ruth Northcutt - Raleigh NC
Allison Ruth Northcutt - Raleigh NC
Assignee:
SmithKline Beecham Corporation - Philadelphia PA
International Classification:
A61K 31437
US Classification:
514292, 514183, 5142305, 51425406, 514284, 514304, 514305, 514306, 514394, 514397
Abstract:
This invention relates to the use of 5-HT3 receptor antagonists in the treatment of nonconstipated female IBS patients.
Kappa-Opiate Agonists For The Treatment Of Diarrhea-Predominant Irritable Bowel Syndrome
US Patent:
7960429, Jun 14, 2011
Filed:
Mar 7, 2008
Appl. No.:
12/044906
Inventors:
Allen Mangel - Chapel Hill NC, US
Assignee:
Tioga Pharmaceuticals, Inc - San Diego CA
International Classification:
A61K 31/40
US Classification:
514424
Abstract:
The present invention concerns methods useful in treating a subject having diarrhea-predominant IBS (IBS-D) by administering N methyl-N-[(1S)-1-phenyl-2-((3S)-3-hydroxypyrrolidin-1-yl)ethyl]-2,2-diphenylacetamide and/or a pharmaceutically acceptable salt thereof to the subject.
Methods Of Treating Irritable Bowel Syndrome And Functional Dyspepsia
US Patent:
2004007, Apr 15, 2004
Filed:
Aug 7, 2003
Appl. No.:
10/467391
Inventors:
Brian Huber - Durham NC, US
Allen Mangel - Chapel Hill NC, US
Allen Mangel - Chapel Hill NC, US
International Classification:
A61K031/522
US Classification:
514/263200, 514/263220, 514/263350, 514/263360
Abstract:
The present invention relates to the use of certain glycol derivatives of xanthines for the treatment of irritable bowel syndrome and functional dyspepsia.
Kappa-Opiate Agonists For The Treatment Of Diarrhea-Predominant Irritable Bowel Syndrome
US Patent:
2011004, Feb 24, 2011
Filed:
Nov 5, 2010
Appl. No.:
12/940979
Inventors:
Allen MANGEL - Chapel Hill NC, US
Assignee:
Tioga Pharmaceuticals, Inc. - San Diego CA
International Classification:
A61K 31/40, A61K 31/438, A61P 1/00, A61P 1/12, A61P 29/00
US Classification:
514292, 514424
Abstract:
The present invention concerns methods useful in treating a subject having diarrhea-predominant IBS (IBS-D) by administering N-methyl-N-[(1S)-1-phenyl-2-((3S)-3-hydroxypyrrolidin-1-yl)ethyl]-2,2-diphenylacetamide and/or a pharmaceutically acceptable salt thereof to the subject.
Medicaments For The Treatment Of Non-Constipated Female Irritable Bowel Syndrome
US Patent:
6284770, Sep 4, 2001
Filed:
Apr 5, 2000
Appl. No.:
9/529050
Inventors:
Allen Wayne Mangel - Chapel Hill NC
Allison Ruth Northcutt - Raleigh NC
Allison Ruth Northcutt - Raleigh NC
Assignee:
Glaxo Wellcome Inc. - Research Triangle Park NC
International Classification:
A61K 31437
US Classification:
514292
Abstract:
This invention relates to the use of 5-HT3 receptor antagonists in the treatment of nonconstipated female IBS patients.
Use Of Cox-2 Inhibitors For Constipation
US Patent:
2003001, Jan 16, 2003
Filed:
Jul 25, 2002
Appl. No.:
10/182169
Inventors:
Allen Mangel - Chapel Hill NC, US
Alan Naylor - Stevenage, GB
Alan Naylor - Stevenage, GB
International Classification:
A61K031/503, A61K031/4745, A61K031/365, A61K031/415, A61K031/18
US Classification:
514/248000, 514/303000, 514/374000, 514/406000, 514/470000, 514/605000
Abstract:
The invention provides a COX-2 inhibitor or a pharmaceutically acceptable derivative thereof for use in the treatment of constipation.
Method For Treating Functional Dyspepsia
US Patent:
2003018, Oct 2, 2003
Filed:
Nov 14, 2002
Appl. No.:
10/276238
Inventors:
Allen Mangel - Chapel Hill NC, US
International Classification:
A61K031/4745
US Classification:
514/292000
Abstract:
This invention relates to the use of alosetron in the treatment or functional dyspepsia.
Use Of Cox-2 Inhibitors As Gastroprokinetics
US Patent:
2004019, Sep 30, 2004
Filed:
Feb 25, 2004
Appl. No.:
10/786423
Inventors:
Allen Mangel - Chapel Hill NC, US
Alan Naylor - Stevenage, GB
Alan Naylor - Stevenage, GB
International Classification:
A61K031/50, A61K031/503, A61K031/415, A61K031/365, A61K031/18
US Classification:
514/247000, 514/303000, 514/406000, 514/471000, 514/602000, 514/248000
Abstract:
The invention provides a COX-2 inhibitor or a pharmaceutically acceptable derivative thereof for use in the treatment of a disorder ameliorated by a gastroprokinetic.